Polysaccharides from the Edible Mushroom Agaricus bitorquis (Quél.) Sacc. Chaidam Show Anti-hypoxia Activities in Pulmonary Artery Smooth Muscle Cells

Int J Mol Sci. 2019 Feb 1;20(3):637. doi: 10.3390/ijms20030637.

Abstract

Three kinds of new water-soluble polysaccharides (FA, FB and FC) were isolated from wild mushroom Agaricus bitorquis (Quél.) Sacc. Chaidam by the classical method "water extraction and alcohol precipitation" and purified by column chromatography. The Mw of FA, FB and FC ranged from 5690 Da to 38,340 Da. The three polysaccharide fractions in the fruiting body were mainly composed of 4 kinds of monosaccharides, including glucose, galactose, mannose, and arabinose, among which glucose and galactose were the major monosaccharides. The FTIR and NMR spectroscopy indicated that the skeleton of three fractions composed of a (1→4)-α-D-glycosidic backbone containing α-D-mannopyranose. In vitro anti-hypoxia activity data showed that three polysaccharide fractions possessed a significant effect on inhibiting PASM cells apoptosis under hypoxia. Among them, FC at the concentration of 200 µg/mL revealed a significant anti-hypoxia effect. These results revealed that the intracellular polysaccharides possessed potent anti-hypoxic activity, which might be related to inhibiting LDH and NADPH oxidase expression and promoting the formation of 5-hydroxytryptamine, dopamine, endothelins, acetylcholine. More importantly, FC showed good performance inducing KV1.5 expression and prohibiting KIR6.2 formation at protein level.

Keywords: Agaricus bitorquis (Quél.) Sacc. Chaidam; anti-hypoxia activity; intracellular polysaccharides; structural characterization.

MeSH terms

  • Agaricus / chemistry*
  • Arabinose / chemistry
  • Carbohydrate Sequence
  • Cell Hypoxia
  • Cell Line
  • Cell Survival / drug effects
  • Chemical Fractionation / methods
  • Fruiting Bodies, Fungal / chemistry
  • Fungal Polysaccharides / chemistry
  • Fungal Polysaccharides / isolation & purification
  • Fungal Polysaccharides / pharmacology*
  • Galactose / chemistry
  • Gene Expression Regulation / drug effects*
  • Glucose / chemistry
  • Humans
  • Kv1.5 Potassium Channel / agonists
  • Kv1.5 Potassium Channel / genetics
  • Kv1.5 Potassium Channel / metabolism
  • L-Lactate Dehydrogenase / antagonists & inhibitors
  • L-Lactate Dehydrogenase / genetics
  • L-Lactate Dehydrogenase / metabolism
  • Mannose / chemistry
  • Myocytes, Smooth Muscle / cytology
  • Myocytes, Smooth Muscle / drug effects*
  • Myocytes, Smooth Muscle / metabolism
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / genetics
  • NADPH Oxidases / metabolism
  • Oxygen / pharmacology
  • Potassium Channels, Inwardly Rectifying / antagonists & inhibitors
  • Potassium Channels, Inwardly Rectifying / genetics
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Protective Agents / chemistry
  • Protective Agents / isolation & purification
  • Protective Agents / pharmacology*
  • Pulmonary Artery / cytology
  • Pulmonary Artery / metabolism

Substances

  • Fungal Polysaccharides
  • KCNA5 protein, human
  • Kir6.2 channel
  • Kv1.5 Potassium Channel
  • Potassium Channels, Inwardly Rectifying
  • Protective Agents
  • Arabinose
  • L-Lactate Dehydrogenase
  • NADPH Oxidases
  • Glucose
  • Mannose
  • Oxygen
  • Galactose